Search
for
Sort by
Research 31–60 of 78
- Post-finasteride syndrome - a true clinical entity?
- Finasteride and sexual side effects
- Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study
- Guidelines on the use of finasteride in androgenetic alopecia
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
- Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: a serious concern or red herring?
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- Elucidation of the Potential Hair Growth-Promoting Effect of Botryococcus terribilis, Its Novel Compound Methylated-Meijicoccene, and C32 Botryococcene on Cultured Hair Follicle Dermal Papilla Cells Using DNA Microarray Gene Expression Analysis
- The connection of 5-alpha reductase inhibitors to the development of depression
- The post-finasteride syndrome: possible etiological mechanisms and symptoms
- Tackling Adverse Effects
- Possibilities and Limitations for Reversal of Age-Related Hair Loss
- Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
- Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports
- Male androgenetic alopecia
- 5-Alpha-Reductase Inhibitors in the Treatment of Male Androgenetic Alopecia: Clinical Experience
- Hair Loss: Advances and Treatments
- Beliefs and counseling practices among dermatologists regarding sexual and other adverse effects of finasteride
- Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis
- Caffeine as an Active Ingredient in Cosmetic Preparations Against Hair Loss: A Systematic Review of Available Clinical Evidence
- Novel Technologies for Exploring the Skin–Brain Axis
- The difficult hair loss patient: A particular challenge
- Response to: “finasteride prescribed for hair loss consistently leads to depression”
- Oral finasteride use and sexual adverse events: signal detection from disproportionality analyses of data from the United States Food and Drug Administration Adverse Event Reporting System
- Comment on Current Investigations into the Postfinasteride Syndrome
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Open-label placebos reduce hair cortisol concentrations and psychological distress - a randomized controlled trial